GLP-1 receptor raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-03-01. Anything still debated is marked as such rather than presented as settled.
Receptor activation occurs at GLP-1 receptors distributed across pancreatic islets, the hypothalamus, and the gastrointestinal tract. Binding triggers G protein signaling that raises cyclic AMP and enhances glucose-dependent insulin release. Because the effect depends on prevailing glucose levels, insulin secretion does not rise when blood sugar is already low. Signaling in the brain and gut also influences appetite and gastric emptying, which is why the compound appears in both metabolic and weight-related research literature.
Development began in the early 2010s with the goal of extending GLP-1 activity beyond the brief window achieved by native peptide infusion. The earliest approved formulation was a subcutaneous injection given once weekly. A later oral tablet pairs the peptide with an absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, usually shortened to SNAC. That carrier lowers local pH and helps the peptide cross gastric tissue. Both routes deliver the same active molecule.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.
Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide, GLP-1 receptor agonist | Not a small molecule |
| Backbone substitutions | Non-natural residue at position 8, arginine at position 34 | Slows enzymatic cleavage |
| Side chain | C18 fatty diacid with PEG linker | Enables albumin binding |
| Approximate molecular mass | 4114 Da | Varies slightly with salt form |
| Reported half-life | About one week | Longer than native GLP-1 by orders of magnitude |
== Other == Civic Democratic Party (Czech: Občanská demokratická strana) Civic Democratic Party (Slovakia) (Slovak: Občianska demokratická strana) Odesa International Airport, an airport in Odesa, Ukraine (IATA code ODS) L'Officiel du jeu Scrabble, the reference dictionary for Scrabble in French-speaking countries One Day School, a gifted education program in New Zealand. Operating Deflection Shape, a method used for visualisation of the vibration pattern of a machine Ordbog over det danske Sprog, a dictionary of Danish Overdoses (especially drug overdoses) In Liverpool in England, Old Dock Sill Orbital Dysfunctional Syndrome from the film Pandorum Occupy Dame Street, a protest in Dublin, Ireland in 2011–12
Each facility operating an x-ray unit shall have sufficient personnel with appropriate expertise. The person responsible for radiation protection or one or more Radiation Safety Officers shall have appropriate qualifications, which shall be regularly updated. X-ray examinations may be technically performed by any other staff member of a medical or dental practice if they are under the direct supervision and responsibility of the person responsible and if they have knowledge of radiation protection. This knowledge of radiation protection has been required since the amendment of the X-ray Ordinance in 1987; medical and dental assistants (then called medical assistants or dental assistants) received this additional training in 1990. The regulations for the specialty of radiology were tightened by the Radiation Protection Act, which came into force on October 1, 2017. The handling of radioactive substances and ionizing radiation (if not covered by the X-ray Ordinance) is regulated by the Radiation Protection Ordinance (StrlSchV). Section 30 StrlSchV § 30 StrlSchV (in German) defines the "Required expertise and knowledge in radiation protection".
== Functions == Endorphins play a major role in the body's inhibitory response to pain. Research has demonstrated that meditation by trained individuals can be used to trigger endorphin release. Laughter may also stimulate endorphin production and elevate one's pain threshold. Endorphin production can be triggered by vigorous aerobic exercise. The release of β-endorphin has been postulated to contribute to the phenomenon known as "runner's high". However, experimental blockade of the mu opioid receptor has shown that endorphins are not strictly necessary for the development of exercise-induced euphoria. It has been suggested that other neurotransmitters, namely endocannabinoids, are more likely contributors. Endorphins may partially mediate exercise-induced analgesia.
== Matrix assembly == Cellular fibronectin is assembled into an insoluble fibrillar matrix in a complex cell-mediated process. Fibronectin matrix assembly begins when soluble, compact fibronectin dimers are secreted from cells, often fibroblasts. These soluble dimers bind to α5β1 integrin receptors on the cell surface and aid in clustering the integrins. The local concentration of integrin-bound fibronectin increases, allowing bound fibronectin molecules to more readily interact with one another. Short fibronectin fibrils then begin to form between adjacent cells. As matrix assembly proceeds, the soluble fibrils are converted into larger insoluble fibrils that comprise the extracellular matrix. Fibronectin's shift from soluble to insoluble fibrils proceeds when cryptic fibronectin-binding sites are exposed along the length of a bound fibronectin molecule. Cells are believed to stretch fibronectin by pulling on their fibronectin-bound integrin receptors. This force partially unfolds the fibronectin ligand, unmasking cryptic fibronectin-binding sites and allowing nearby fibronectin molecules to associate. This fibronectin-fibronectin interaction enables the soluble, cell-associated fibrils to branch and stabilize into an insoluble fibronectin matrix. A transmembrane protein, CD93, has been shown to be essential for fibronectin matrix assembly (fibrillogenesis) in human dermal blood endothelial cells. As a consequence, knockdown of CD93 in these cells resulted in the disruption of the fibronectin fibrillogenesis.
== Cause == Aside from L. odoratus, other members of the genus are also known to cause the disease, including L. sylvestris, L. cicera, and L. clymenum. L. odoratus grows well under famine conditions, often severe drought, where it is cultivated. These legumes carry a variety of osteolathyrogenic compounds, specifically excitatory amino-compounds. The most widely studied of these compounds is beta-aminopropionitrile (BAPN), which exerts its deleterious effect by an unknown yet potently irreversible mechanism. Other instigators are ureides, semicarbazides and thiosemicarbazides, which are believed to chelate the prosthetic Cu(II)-bipyridine cofactor complex in the enzyme lysyl oxidase. Lysyl oxidase is an important enzyme for the creation of crosslinks between collagen triple-helices in connective tissue. By oxidizing the terminal amino group of lysine, an aldehyde is created. This aldehyde can undergo several reactions with neighboring aldehydes or amines to create strong covalent cross-links between collagen tertiary structures in bone and cartilage. The main product of these reactions is the aldimine compound dehydrohydroxylysinonorleucine. This unique crosslink can be formed by the Schiff base mechanism in which the lone pair of electrons on a primary amine react with the carbonyl carbon of an aldehyde. Other crosslinks include the formation of an α,β-unsaturated ketone via aldol condensation and hydroxylysinonorleucine. If these crosslinks are not formed, as in the case of osteolathyrism, the synthesis of strong mesenchymal and mesodermal tissue is inhibited.
Sources: en.wikipedia.org
== Iron-60 == Iron-60 has a half-life of 2.62 million years, but was thought until 2009 to have a half-life of 1.5 million years. It undergoes beta decay to 60Co, which then decays with the much shorter half-life of about 5 years to stable 60Ni. In phases of the meteorites Semarkona and Chervony Kut, a correlation between the excess concentration of 60Ni, the granddaughter isotope of 60Fe, and the abundance of the stable iron isotopes could be found, which is evidence for the existence of 60Fe at the time of formation of the Solar System. Depending on its original abundance, the energy from the decay of 60Fe may have been significant, along with that of 26Al, to the remelting and differentiation of asteroids and planetesimals after their formation. These nickel abundances in extraterrestrial materials may also provide further insight into the origin of the Solar System and its early history. Live (interstellar) iron-60 was first identified in deep sea sediments in 1999. These are deep sea ferromanganese crusts, which are constantly growing, aggregating iron, manganese, and other elements. Iron-60 has been found in fossilized bacteria in sea floor sediments. In 2019, researchers found 60Fe in Antarctica. Iron-60 shows two peaks in deep sea sediments, the first 1.7–3.2 million years ago and the second 6.5–8.7 million years ago. The peaks are related to the passage of the Solar System through the Local Bubble and likely the Orion–Eridanus Superbubble. These superbubbles were created by multiple supernovae. Traces of iron-60 have also been found in lunar samples.
=== Pregnancy and lactation === The use of dalbavancin in pregnant women has not been studied sufficiently and should only occur when the potential benefit outweighs the potential risk to the fetus. Animal studies did not show embryo or fetal toxicity at doses that were 1.2 and 0.7 times the human dose. However, delayed fetal maturation was observed at a dose that was 3.5 times the human dose. While dalbavancin is excreted in rat milk, it is unknown if it is excreted in human milk. It should be used in nursing mothers only when the potential benefit exceeds the potential risk. There is no evidence in animals of teratogenicity.
Pharmacy is the science and practice of dispensing, preparing, reviewing safety and efficacy, monitoring, discovering, producing, and consulting about medications, aiming to ensure the safe, effective, and affordable use of medicines. It is an interdisciplinary science as it links health sciences, pharmaceutical sciences, and natural sciences with the humanities. The professional practice is clinically oriented, with most drugs now being manufactured by pharmaceutical industries and prescribed in the medical setting. Based on the setting, pharmacy practice is either classified as community or institutional pharmacy. Providing direct patient care is considered clinical pharmacy, mainly practiced in institutions like hospitals, long-term care facilities, hospice, ambulatory clinics, or psychiatric hospitals. However, more clinical application are becoming important in the community setting to combat barriers to accessing healthcare (e.g., immunizations, point of care testing, oral contraceptive prescribing, administering injectable therapies, suggesting OTC products, or prescribing under Physician backed protocols). The scope of pharmacy practice includes more traditional roles such as dispensing and compounding of medications based on compendiums, like the USP. It also includes more modern services related to health care including clinical services involving medical guideline appropriateness, reviewing medications for safety and efficacy, and providing drug information with patient counselling.
== Term == The term thrombocyte (clot cell) came into use in the early 1900s and is sometimes used as a synonym for platelet; but not generally in the scientific literature, except as a root word for other terms related to platelets (e.g. thrombocytopenia meaning low platelets). The term thrombocytes is proper for mononuclear cells found in the blood of non-mammalian vertebrates: they are the functional equivalent of platelets, but circulate as intact cells rather than cytoplasmic fragments of bone marrow megakaryocytes. In some contexts, the word thrombus is used interchangeably with the word clot, regardless of its composition (white, red, or mixed). In other contexts it is used to contrast a normal from an abnormal clot: thrombus arises from physiologic hemostasis, thrombosis arises from a pathologic and excessive quantity of clot. In a third context it is used to contrast the result from the process: thrombus is the result, thrombosis is the process.
Sources: en.wikipedia.org
=== Ontogeny and life history === Neanderthal brain size at birth was similar to modern humans and constrained by the same obstetric factors; mothers giving birth to infants with heads too large to pass through the birth canal would be selected against. Growth in brain volume occurred at a faster pace in Neanderthal infants than in modern human infants, but growth of the brain did not reach completion earlier in Neanderthals than in modern humans owing to the larger brain size of the former. The rate of incisor crown formation in Neanderthals is also indicative of an accelerated pattern of life history relative to modern humans. Estimates of the age at weaning of Neanderthals vary. Barium levels in the enamel of a Belgian Neanderthal tooth from Scladina suggest a weaning age of 1.2 years. Trace element analysis of a Neanderthal tooth from Payre suggests that weaning occurred at about 2.5 years of age.
== Toxicity == Since 2016, G. biloba extract is classified as a possible human carcinogen (group 2B) by the International Agency for Research on Cancer. When eaten in large quantities or over a long period, the seeds may cause poisoning by ginkgotoxin (4'-O-methylpyridoxine, MPN), as found in a few case reports. A heat-stable compound not destroyed by cooking, MPN may cause convulsions, which were alleviated by treatment with pyridoxine phosphate (vitamin B6), according to limited studies. Some people are sensitive to the chemicals in the sarcotesta, the outer fleshy coating. These people should handle the seeds with care, wearing disposable gloves, when preparing them for consumption. The symptoms are allergic contact dermatitis, or blisters similar to that caused by contact with poison ivy. Side effects of using ginkgo supplements may include increased risk of bleeding, gastrointestinal discomfort, nausea, vomiting, diarrhea, headaches, dizziness, heart palpitations, and restlessness. Although use of standardized Ginkgo biloba leaf extracts in moderate amounts appears to be safe, excessive use may have undesirable effects, especially in terms of drug interactions. The dosing of anticoagulants, such as warfarin or antiplatelet medication, may be adversely affected by using ginkgo supplements. According to a systematic review, the effects of ginkgo on pregnant women may include increased bleeding time, and there is inadequate information about safety during lactation. Ginkgo pollen may produce allergic reactions. G.
Fast recognition and treatment of MH utilizes skills and procedures that are utilized with a low-frequency and high-risk. Conducting MH crisis training for perioperative teams can identify system failures as well as improve response to these events. Simulation techniques to include the use of cognitive aids have also been shown to improve communication in clinical treatment of MH.
Sources: en.wikipedia.org
Native GLP-1 is degraded within minutes by circulating enzymes. The synthetic version carries substitutions at positions that block enzymatic cleavage, plus a fatty acid side chain that promotes albumin binding. These two changes together extend circulation time from minutes to roughly a week.
Albumin binding keeps a large fraction of the compound in a slowly released reservoir within the bloodstream. Plasma levels decline gradually rather than falling sharply after each administration. That profile supports dosing intervals measured in days instead of hours.
The active peptide sequence is the same in both formats. The oral version adds an absorption enhancer that is not present in the injected solution. Differences in excipients and formulation affect uptake rather than the identity of the active molecule.
Native GLP-1 is degraded within minutes by dipeptidyl peptidase-4 and cleared quickly. Semaglutide carries a position 8 substitution that blocks that cleavage and a fatty diacid chain that binds albumin. Together these changes extend its circulating half-life to about one week.